Kither Biotech announces publication of new data in Science Translational Medicine Kither Biotech announces publication of new data in Science Translational Medicine Data support the use of Kither Biotech’s lead asset, KIT2014, in obstructive airway diseases KIT2014 demonstrated a...

Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer Proceeds to support the further development of lead asset KIT2014 in cystic fibrosis through...